FDA Law Blog
MARCH 19, 2024
is pleased to announce that Director Allyson Mullen has been appointed to the Board of Directors of the Association of Medical Diagnostic Manufacturers (AMDM). This prestigious appointment recognizes Ms. Speaking about her appointment, Ms. (HP&M), the largest dedicated food and drug law firm in the U.S.,
The Medical Futurist
JUNE 17, 2025
Rather, it’s a dental professional who can demonstrate the proper techniques at your next appointment. Computer-assisted design (CAD) and computer-assisted manufacture (CAM), including 3D-printing, are already revolutionising the sector; they are turning them into low-cost, more effective digital labs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Medical Futurist
JUNE 21, 2025
It’s obvious what a potential removing language barriers holds for medical appointments. The situation today is as follows: One company manufactures software for the radiology department which use a certain format of AI in their daily work. Just as we’ve seen how live translation works with ChatGPT-4o.
CDOCS
JUNE 23, 2021
& A core file is then returned to design and manufacture the bridge.& & This workflow involves less appointments and results in an excellent fitting bridge. A three-unit zirconia bridge was designed and manufactured (image 14).& software (image 13).
FDA Law Blog
JUNE 16, 2023
Kirschenbaum — On May 24, Minnesota enacted the Commerce and Consumer Protection Omnibus Bill, Senate File 2744 ( SF 2744 ), which significantly expands the state’s existing drug pricing activities with serious implications for all drug manufacturers, and particularly generic drug manufacturers. We address each below. Best price?
CDOCS
SEPTEMBER 29, 2021
5mm CS finisher to create extra detailed anatomy and minimize finishing after the manufacturer process.</span></p> & The Extra Fine milling certainly extended the time compared to the Super Fast milling, but even with the extra milling time, the total appointment time fell into an acceptable range.&
FDA Law Blog
OCTOBER 1, 2024
Or consider Vanda’s challenge that FDA’s approval of a generic version of one of the company’s drugs violated the Appointments Clause of the Constitution (U.S. Murphy, Director of the Office of Generic Drugs’] ratification cured any Appointments Clause deficiency because it is unclear whether any statute properly authorized her appointment.
Expert insights. Personalized for you.
59 
Let's personalize your content